DJIA 17,523.87 -159.71 -0.90%
NASDAQ 4,920.82 -71.12 -1.42%
S&P 500 2,056.70 -12.06 -0.58%
market minute promo

AstraZeneca plc (ADR) (NYSE: AZN)



company name or ticker
Company Photos
(Click to zoom)

Your Biotech Could Be a Buyout Target -- But Don't Bet on It

It doesn't really matter what the CEO of a major pharmaceutical company says.

US Stock Futures Surge Ahead Of ADP Report, Beige Book

Stocks Slip on Greece Worries, Bond Yields Hit Two-Week Highs

Why Shares in Regulus Therapeutics Inc. Are Tumbling

Regulus Therapeutics CEO is leaving to pursue other opportunities, casting doubt on Regulus Therapeutics' potential.

Report: AstraZeneca Might Bid On Juno Therapeutics

Why I Bought The Dip In Amgen: Focus On Repatha And Other Aspects Of The Pipeline

AstraZeneca Presents Data at ASCO; Inks Deal with Eli Lilly - Analyst Blog

AstraZeneca Presents Data at ASCO; Inks Deal with Eli Lilly - Analyst Blog

Some Side Effect For An Antibody

Puma Biotech Hoping for a Bounce at Annual Meeting of Cancer Society

Clovis Wins One ASCO '15 Battle, Loses Another, Against Rival AstraZeneca

See More Articles...